Impact of duration of mechanical support on heart transplantation: Hasty transplantation may not have a good long‐term outcome

Background Mechanical circulatory support (MCS) has been widely utilized in critically ill cardiac transplant candidates. Few studies have investigated the impact of duration of MCS before heart transplantation (HTx) on long‐term patient survival. Methods A retrospective HTx database was reviewed be...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical transplantation 2022-11, Vol.36 (11), p.e14746-n/a
Hauptverfasser: Yu, Sz‐Han, Chou, Heng‐Wen, Wang, Chih‐Hsien, Tsao, Chuan‐I, Fu, Hsun‐Yi, Chen, Kevin Po‐Hsun, Chi, Nai‐Hsin, Huang, Shu‐Chien, Chou, Nai‐Kuan, Hsu, Ron‐Bin, Yu, Hsi‐Yu, Lin, Jou‐Wei, Chen, Yih‐Sharng
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Mechanical circulatory support (MCS) has been widely utilized in critically ill cardiac transplant candidates. Few studies have investigated the impact of duration of MCS before heart transplantation (HTx) on long‐term patient survival. Methods A retrospective HTx database was reviewed between 2009 and 2019. Patients who did not or did undergo MCS before HTx were categorized into two groups: (1) A (did not) and (2) B (did), respectively. A receiver operating characteristic (ROC) curve was plotted to assess the cutoff level of MCS duration before HTx in evaluating 5‐year survival. Result A total of 270 HTx patients (group A: 120, group B: 150) were analyzed. Group B patients had a higher percentage of blood type O, a higher incidence of resuscitation, a shorter listing duration, and a higher likelihood of having United Network for Organ Sharing (UNOS) 1A status than group A. The ROC curve revealed 24 days as a good cut‐off level for determining the best MCS before HTx timing. Group B was categorized into two subgroups: (1) B1 (MCS  24 days, n = 85). B2 had a higher incidence of cardiopulmonary resuscitation (CPR), hemodialysis, longer waiting time after MCS, and better ventricular assist device implantation than B1. However, the survival curves showed that B1 outcomes were significantly worse than in groups A and B2. Groups A and B2 had similar survival curves without an increased incidence of infection. Conclusion The preliminary data demonstrated that a longer duration of MCS may be associated with better outcomes than urgent HTx.
ISSN:0902-0063
1399-0012
DOI:10.1111/ctr.14746